18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
NCT04588454 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2021-01-27
Summary
This is a pilot study to determine uptake of PET tracer 18F-PSMA-1007 in primary glioblastoma.
Conditions
Interventions
- OTHER
-
18F-PSMA-1007 PET tracer
18F-PSMA-1007 PET/CT
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-17
- Primary Completion
- 2020-10-31
- Completion
- 2021-06-01
Countries
- Netherlands
Study Locations
More Related Trials
-
[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the Brain
NCT06148207 ·Status: RECRUITING ·Phase: NA
-
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
NCT01579253 ·Status: UNKNOWN
-
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
NCT02020720 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Image-Guided Stereotactic Biopsy of High Grade Gliomas
NCT00979810 ·Status: COMPLETED ·Phase: NA
-
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
NCT01089868 ·Status: COMPLETED
-
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
NCT03242824 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas
NCT06499831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
NCT05970757 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas
NCT07017790 ·Status: NOT_YET_RECRUITING
-
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745 ·Status: TERMINATED ·Phase: NA
-
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
NCT06241391 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
NCT02371031 ·Status: TERMINATED ·Phase: PHASE1
-
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
NCT01800032 ·Status: COMPLETED
-
Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas
NCT04469244 ·Status: COMPLETED
-
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
NCT05212272 ·Status: RECRUITING ·Phase: NA
-
68Ga-NOTA-RM26 PET/CT in Glioma Patients
NCT06412952 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
NCT00589095 ·Status: TERMINATED
-
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
NCT03102203 ·Status: UNKNOWN
-
Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
NCT01880008 ·Status: COMPLETED
-
Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
NCT00943007 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
NCT01117155 ·Status: WITHDRAWN
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
NCT01089244 ·Status: UNKNOWN
-
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NCT07119294 ·Status: RECRUITING ·Phase: NA